76 related articles for article (PubMed ID: 22647587)
41. Occupational Characteristics and Patterns as Risk Factors for Parkinson's Disease: A Case Control Study.
Sullivan KL; Mortimer JA; Wang W; Zesiewicz TA; Brownlee HJ; Borenstein AR
J Parkinsons Dis; 2015; 5(4):813-20. PubMed ID: 26444091
[TBL] [Abstract][Full Text] [Related]
42. Is there a connection between estrogen and Parkinson's disease?
Shulman LM
Parkinsonism Relat Disord; 2002 Jun; 8(5):289-95. PubMed ID: 15177058
[TBL] [Abstract][Full Text] [Related]
43. Menstrual and Reproductive Factors and Risk of Pancreatic Cancer in Women.
Masoudi S; Momayez Sanat Z; Mahmud Saleh A; Nozari N; Ghamarzad N; Pourshams A
Middle East J Dig Dis; 2017 Jul; 9(3):146-149. PubMed ID: 28894516
[TBL] [Abstract][Full Text] [Related]
44. Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, Iran.
Salari M; Mirmosayyeb O; Etemadifar M; Shaygannejad V; Khorvash F; Najafi MR; Ashtari F; Chitsaz A
Iran J Neurol; 2018 Jan; 17(1):6-10. PubMed ID: 30186553
[No Abstract] [Full Text] [Related]
45. The complexities of hormonal influences and risk of Parkinson's disease.
Marras C; Saunders-Pullman R
Mov Disord; 2014 Jun; 29(7):845-8. PubMed ID: 24789470
[No Abstract] [Full Text] [Related]
46. Assessment of Pulmonary Functions in Parkinson's Disease and Unveiling the Role of Levodopa Therapy: A Cross-Sectional Study.
Mishra O; Mallik AK; Dash SK; Das P; Dash M
Cureus; 2024 Apr; 16(4):e58662. PubMed ID: 38774174
[TBL] [Abstract][Full Text] [Related]
47. The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease.
Shiraishi T; Bono K; Hiraki H; Manome Y; Oka H; Iguchi Y; Okano HJ
Cell Mol Life Sci; 2024 Feb; 81(1):103. PubMed ID: 38409392
[TBL] [Abstract][Full Text] [Related]
48. Reproductive characteristics, use of exogenous hormones and Parkinson disease in women from the E3N study.
Pesce G; Artaud F; Roze E; Degaey I; Portugal B; Nguyen TTH; Fournier A; Boutron-Ruault MC; Severi G; Elbaz A; Canonico M
Brain; 2023 Jun; 146(6):2535-2546. PubMed ID: 36415953
[TBL] [Abstract][Full Text] [Related]
49. State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us.
Unda SR; Marciano S; Milner TA; Marongiu R
Front Aging Neurosci; 2022; 14():971007. PubMed ID: 36337706
[TBL] [Abstract][Full Text] [Related]
50. Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.
Mehanna R; Smilowska K; Fleisher J; Post B; Hatano T; Pimentel Piemonte ME; Kumar KR; McConvey V; Zhang B; Tan EK; Savica R;
Mov Disord Clin Pract; 2022 Oct; 9(7):869-878. PubMed ID: 36247919
[TBL] [Abstract][Full Text] [Related]
51. Annual Cost of Care of Parkinson's Disease and Its Determinants in North India - A Cost of Illness Study with Patient Perspective.
Ola V; Puri I; Goswami D; Vibha D; Shukla G; Goyal V; Srivastava A; Behari M
Ann Indian Acad Neurol; 2022; 25(4):660-663. PubMed ID: 36211186
[TBL] [Abstract][Full Text] [Related]
52. Modulation by Estradiol of L-Dopa-Induced Dyskinesia in a Rat Model of Post-Menopausal Hemiparkinsonism.
Kolmančič K; Živin M; Zorović M
Life (Basel); 2022 Apr; 12(5):. PubMed ID: 35629308
[TBL] [Abstract][Full Text] [Related]
53. Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson's disease.
Su XL; Luo XG; Lv H; Wang J; Ren Y; He ZY
Transl Neurodegener; 2017; 6():14. PubMed ID: 28580139
[TBL] [Abstract][Full Text] [Related]
54. Research in Parkinson's disease in India: A review.
Surathi P; Jhunjhunwala K; Yadav R; Pal PK
Ann Indian Acad Neurol; 2016; 19(1):9-20. PubMed ID: 27011622
[TBL] [Abstract][Full Text] [Related]
55. Psychiatric aspects of Parkinson's disease.
Grover S; Somaiya M; Kumar S; Avasthi A
J Neurosci Rural Pract; 2015 Jan; 6(1):65-76. PubMed ID: 25552854
[TBL] [Abstract][Full Text] [Related]
56. Parkinson disease in the elderly adult.
Willis AW
Mo Med; 2013; 110(5):406-10. PubMed ID: 24279192
[TBL] [Abstract][Full Text] [Related]
57. Estrogen synthesis and signaling pathways during aging: from periphery to brain.
Cui J; Shen Y; Li R
Trends Mol Med; 2013 Mar; 19(3):197-209. PubMed ID: 23348042
[TBL] [Abstract][Full Text] [Related]
58. A case control study of women with Parkinson's disease and their fertility characteristics.
Yadav R; Shukla G; Goyal V; Singh S; Behari M
J Neurol Sci; 2012 Aug; 319(1-2):135-8. PubMed ID: 22647587
[TBL] [Abstract][Full Text] [Related]
59. Reproductive life characteristics in females affected with Parkinson's disease and in healthy control subjects - a comparative study on Polish population.
Nitkowska M; Czyżyk M; Friedman A
Neurol Neurochir Pol; 2014; 48(5):322-7. PubMed ID: 25440010
[TBL] [Abstract][Full Text] [Related]
60. Parkinson's disease and reproductive life events.
Martignoni E; Nappi RE; Citterio A; Calandrella D; Corengia E; Fignon A; Zangaglia R; Riboldazzi G; Pacchetti C; Nappi G
Neurol Sci; 2002 Sep; 23 Suppl 2():S85-6. PubMed ID: 12548356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
